Protagenic Therapeutics, Inc.\new
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-210.9K | $362.5K |
| FY2019 | — | $-634.4K | $798.6K |
| FY2020 | — | $-1.1M | $671.1K |
| FY2021 | — | $9.9M | — |
| FY2022 | — | $6.9M | — |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-210.9K | $362.5K |
| FY2019 | — | $-634.4K | $798.6K |
| FY2020 | — | $-1.1M | $671.1K |
| FY2021 | — | $9.9M | — |
| FY2022 | — | $6.9M | — |